Highest risk patients with clear-cell renal cell carcinoma benefit from adjuvant everolimus: Clinical trial

United Kingdom News News

Highest risk patients with clear-cell renal cell carcinoma benefit from adjuvant everolimus: Clinical trial
United Kingdom Latest News,United Kingdom Headlines
  • 📰 medical_xpress
  • ⏱ Reading Time:
  • 58 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 26%
  • Publisher: 51%

A secondary analysis from the SWOG S0931 EVEREST trial has found that in the subgroup of patients with clear-cell renal cell carcinoma (RCC) who were at very-high risk of recurrence, those who were treated with everolimus after surgery had a statistically significant improvement in recurrence-free survival compared to patients getting placebo...

retrieved 21 October 2023 from https://medicalxpress.com/news/2023-10-highest-patients-clear-cell-renal-cell.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.Aug 19, 2021Use this form if you have come across a typo, inaccuracy or would like to send an edit request for the content on this page. For general inquiries, please use ourThank you for taking time to provide your feedback to the editors.

Your feedback is important to us. However, we do not guarantee individual replies due to the high volume of messages.to let the recipient know who sent the email. Neither your address nor the recipient's address will be used for any other purpose. The information you enter will appear in your e-mail message and is not retained by Medical Xpress in any form.Get weekly and/or daily updates delivered to your inbox.

This site uses cookies to assist with navigation, analyse your use of our services, collect data for ads personalisation and provide content from third parties. By using our site, you acknowledge that you have read and understand our

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

medical_xpress /  🏆 101. in UK

United Kingdom Latest News, United Kingdom Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

UCSF dementia experts to join peers at annual Clinical Trials on Alzheimer's disease conferenceUCSF dementia experts to join peers at annual Clinical Trials on Alzheimer's disease conferenceDementia experts from UC San Francisco will join their peers from around the globe at the annual Clinical Trials on Alzheimer's Disease (CTAD) conference in Boston from Oct. 24 to 27.
Read more »

Diversity among research staff found to increase participation of underrepresented patients in clinical studiesDiversity among research staff found to increase participation of underrepresented patients in clinical studiesNew research from Boston Medical Center found that research staff who interact with patients of the same race or ethnicity increased the odds of those patients agreeing to participate in clinical studies by almost a factor of 3.
Read more »

Cancer drug that targets two immune-evading tumor tactics performs well in early clinical trialCancer drug that targets two immune-evading tumor tactics performs well in early clinical trialA 'two-for-one' cancer immunotherapy is potentially more effective and at least as safe as standard immunotherapies, physician-scientists from UPMC Hillman Cancer Center who led an international, early-phase clinical trial report in the journal Nature Medicine.
Read more »

Leeds United striker Georginio Rutter told he 'needs to be more clinical'Leeds United striker Georginio Rutter told he 'needs to be more clinical'Rutter already has two goals to his name this season is beginning to flourish at Elland Road
Read more »

Clinical study evaluates safety and efficacy of methylone in patients with severe PTSDClinical study evaluates safety and efficacy of methylone in patients with severe PTSDClerkenwell Health, the modern mental health company specializing in matching patients with cutting-edge psychiatry treatments, today announced that it is taking part in Transcend Therapeutics’ Phase 2 study evaluating the safety and efficacy of methylone in patients with severe PTSD.
Read more »

New clinical trial guidelines set to increase transparency and support progress in developing new therapiesNew clinical trial guidelines set to increase transparency and support progress in developing new therapiesNew guidelines have been developed to help researchers ensure that their clinical trial protocols and reports are complete, high-quality and transparent. Increased consistency across these documents will facilitate comparisons between different studies and reduce research inefficiencies.
Read more »



Render Time: 2025-02-16 06:02:24